Ratings GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
7.13 ^USD	-4.68%		+6.42%	+6.42%

May. 20	Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating	MT
May. 17	UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company's profit outlook over the next few years is a strong asset.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Thanks to a sound financial situation, the firm has significant leeway for investment.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 69.34 times its estimated earnings per share for the ongoing year.
The company appears highly valued given the size of its balance sheet.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
GOODRX HOLDINGS, INC.	+6.42%	2.68B	-
TENCENT HOLDINGS LIMITED	+30.65%	470B	B
NETFLIX, INC.	+31.62%	276B	D+
UBER TECHNOLOGIES, INC.	+5.00%	135B	A-
PROSUS N.V.	+29.96%	94.76B	B+
SPOTIFY TECHNOLOGY S.A.	+64.02%	61.13B	B-
DOORDASH, INC.	+15.24%	46.6B	C+
NASPERS LIMITED	+25.78%	38.08B	C+
COSTAR GROUP, INC.	+0.15%	35.74B	B
PINTEREST, INC.	+15.12%	29.13B	C

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes